Search

Displaying results 3311 - 3320 of 10000 in total
  1. Drug

    Potassium metabisulfite

    go.drugbank.com/drugs/DB15841
    Investigational

    Mixtures: PROCALAMINE SISE 1000 ML(SETLI), PROCALAMINE SISE 500 ML(SETLI)
  2. Drug

    Phosphate ion

    go.drugbank.com/drugs/DB14523
    Investigational

    Mixtures: NUTRIFLEX LIPID PLUS INFUZYONLUK EMULSIYON, 2500 ML, NUTRIFLEX LIPID PLUS INFUZYONLUK EMULSIYON, 1250 ML
  3. Drug

    Benzoin resin

    go.drugbank.com/drugs/DB11222
    Approved

    While benzoin resin is used as a common ingredient in incense-making and perfumery, it is also used clinically as a mild antiseptic agent in over-the-counter products to clean sores, cuts, wounds, and … Benzoin resin is a balsamic resin obtained from the bark of several species of trees in the genus _Styrax_.

  4. Drug

    Nitenpyram

    go.drugbank.com/drugs/DB11438
    ExperimentalVet approved

    It is a neonicotinoid, a neurotoxin that blocks neural messages and binds particularly tightly in the central nervous system of insects, causing rapid death. … Nitenpyram is an insecticide used in agriculture and veterinary medicine to kill external parasites of pets.

    Categories: Compounds used in a research, industrial, or household setting
  5. Drug

    Entecavir

    go.drugbank.com/drugs/DB00442
    ApprovedInvestigational

    Entecavir is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude (BMS). … It was approved by the U.S. Food and Drug Administration (FDA) in March 2005.

    Products: HEPAGARD 0.05 MG/ML ORAL ÇÖZELTI ,240 ML, HEPATOVIR-B 0.05 MG/ML ORAL ÇÖZELTİ, 210 ML
  6. Drug

    Centanafadine

    go.drugbank.com/drugs/DB14841
    ApprovedInvestigational

    [L63806] Its mechanism in ADHD is unclear, but its efficacy may be mediated by this triple reuptake inhibition, which increases the availability of all three neurotransmitters in pathways involved in attention … [L63934] The FDA approved centanafadine on July 24, 2026, for the treatment of ADHD in adults and pediatric patients 6 years of age and older weighing at least 20 kg; use is not recommended below that

  7. Drug

    Minaprine

    go.drugbank.com/drugs/DB00805
    Approved

    Minaprine is a psychotropic drug which has proved to be effective in the treatment of various depressive states. Like most antidepressants minaprine antagonizes behavioral despair. … Minaprine is an amino-phenylpyridazine antidepressant reported to be relatively free of cardiotoxicity, drowsiness, and weight gain.

  8. Drug

    Isoflurophate

    go.drugbank.com/drugs/DB00677
    ApprovedWithdrawn

    It is a powerful miotic used mainly in the treatment of glaucoma. Its vapor is highly toxic and it is recommended that only solutions in arachis oil be used therapeutically.

  9. Drug

    Fucoxanthin

    go.drugbank.com/drugs/DB15462
    Investigational

    Fucoxanthin is under investigation in clinical trial NCT03613740 (Effect of Fucoxanthin on the Components of the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion). … In vivo studies have demonstrated that oral administration of fucoxanthin inhibited carcinogenesis in an animal model of duodenal, skin, colon and liver cancer.

    Mixtures: Oil
  10. Drug

    Nevirapine

    go.drugbank.com/drugs/DB00238
    ApprovedInvestigational

    A potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS.

    Categories: Antivirals used in combination for the treatment of HIV infections